Sitravatinib|CS-2638
Sitravatinib|CS-2638 基本信息更多
- 中文名称:CS-2638
- 中文同义词: 小分子抑制剂(SITRAVATINIB) 化合物SITRAVATINIB 西特拉瓦替尼(MGCD516) N-(3-氟-4-((2-(5-(((2-甲氧基乙基)氨基)甲基)吡啶-2-基)噻吩并[3,2-B]吡啶-7-基)氧基)苯基)-N-(4-氟苯基)环丙烷-1,1-二甲酰胺 司曲替尼 N-[3-氟-4-[[2-[5-[[(2-甲氧基乙基)氨基]甲基]-2-吡啶基]噻吩并[3,2-B]吡啶-7-基]氧基]苯基] -N'-(4-氟苯基)-1,1-环丙烷二甲酰胺
- 英文名称:Sitravatinib
- 英文同义词: Sitravatinib N-(3-fluoro-4-((2-(5-(((2-methoxyethyl)amino)methyl)pyridin-2-yl)thieno[3,2-b]pyridin-7-yl)oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide MGCD-516 MG516 Sitravatinib (MGCD516) CS-2638 1,1-Cyclopropanedicarboxamide, N-[3-fluoro-4-[[2-[5-[[(2-methoxyethyl)amino]methyl]-2-pyridinyl]thieno[3,2-b]pyridin-7-yl]oxy]phenyl]-N'-(4-fluorophenyl)- RTK,MG-516,PD-1,SCFR,DDR1,inhibit,VEGFR2,MG 516,MGCD 516,MER,immune,TRKA,Cluster of differentiation antigen 135,Cancer,Discoidin Domain Receptor,VEGFR3,Inhibitor,Vascular endothelial growth factor receptor,Trk Receptor,Tropomyosin related kinase receptor,CD135,VEGFR,immunotherapy,Macrophages,c-Kit,DDR2,VEGFR1,Tyrosine,Fms like tyrosine kinase 3,FLT3,Axl,TRKB,Sitravatinib,MGCD-516,KIT,kinase,CD117
- CAS号:1123837-84-2
- 分子式:C33H29F2N5O4S
- 分子量:629.68
- EINECS号:
- Mol文件:1123837-84-2.mol
-
